ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]

NL Harris, ES Jaffe, H Stein et al. · Blood · 1994 · 6.3K citations · Full text

Lymphoid Neoplasia, Tumoral Pathology, Medicine +9

ALK− anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

Kerry J. Savage, Nancy L. Harris, Julie M. Vose et al. · Blood · 2008 · 845 citations · Full text

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 707 citations · Full text

Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group

Norbert Schmitz, Lorenz Trümper, Marita Ziepert et al. · Blood · 2010 · 588 citations · Full text

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

Edgardo R. Parrilla Castellar, Elaine S. Jaffe, Jonathan Said et al. · Blood · 2014 · 457 citations · Full text